Back to Search Start Over

Adiposity and risk of decline in glomerular filtration rate : Meta-analysis of individual participant data in a global consortium

Authors :
Chang AR
Grams ME
Ballew SH
Bilo H
Correa A
Evans M
Gutierrez OM
Hosseinpanah F, Iseki K
Kenealy T
Klein B
Kronenberg F
Lee BJ
Li Y
Miura K
Navaneethan SD
Roderick PJ
Valdivielso JM
Visseren FLJ
Zhang L
Gansevoort RT
Hallan SI
Levey AS
Matsushita K
Shalev V
Woodward M
Astor B
Appel L
Greene T
Chen T
Chalmers J
Arima H
Perkovic V
Yatsuya H
Tamakoshi K
Hirakawa Y
Coresh J
Sang Y
Polkinghorne K
Chadban S
Atkins R
Levin A
Djurdjev O
Klein R
Lee K
Liu L
Zhao M
Wang F
Wang J
Tang M
Heine G
Emrich I
Zawada A
Bauer L
Nally J
Schold J
Shlipak M
Sarnak M
Katz R
Hiramoto J
Iso H
Yamagishi K
Umesawa M
Muraki I
Fukagawa M
Maruyama S
Hamano T
Hasegawa T
Fujii N
Jafar T
Hatcher J
Poulter N
Chaturvedi N
Wheeler D
Emberson J
Townend J
Landray M
Brenner H
Schöttker B
Saum KU
Rothenbacher D
Fox C
Hwang SJ
Köttgen A
Schneider MP
Eckardt KU
Green J
Kirchner HL
Ito S
Miyazaki M
Nakayama M
Yamada G
Cirillo M
Romundstad S
Øvrehus M
Langlo KA
Irie F
Sairenchi T
Rebholz CM
Young B
Boulware LE
Ishikawa S
Yano Y
Kotani K
Nakamura T
Jee SH
Kimm H
Mok Y
Chodick G
Wetzels JFM
Blankestijn PJ
van Zuilen AD
Bots M
Inker L
Peralta C
Kollerits B
Ritz E
Nitsch D
Fletcher A
Bottinger E
Nadkarni GN
Ellis SB
Nadukuru R
Fernandez E
Betriu A
Bermudez-Lopez M
Stengel B
Metzger M
Flamant M
Houillier P
Haymann JP
Froissart M
Ueshima H
Okayama A
Tanaka S
Okamura T
Elley CR
Collins JF
Drury PL
Ohkubo T
Asayama K
Metoki H
Kikuya M
Iseki C
Nelson RG
Knowler WC
Bakker SJL
Heerspink HJL
Brunskill N
Major R
Shepherd D
Medcalf J
Jassal SK
Bergstrom J
Ix JH
Barrett-Connor E
Kovesdy C
Kalantar-Zadeh K
Sumida K
Muntner P
Warnock D
Judd S
Panwar B
de Zeeuw D
Brenner B
Sedaghat S
Ikram MA
Hoorn EJ
Dehghan A
Wong TY
Sabanayagam C
Cheng CY
Banu R
Segelmark M
Stendahl M
Schön S
Tangri N
Sud M
Naimark D
Wen CP
Tsao CK
Tsai MK
Chen CH
Konta T
Hirayama A
Ichikawa K
Hadaegh F
Mirbolouk M
Azizi F
Solbu MD
Jenssen TG
Eriksen BO
Eggen AE
Lannfelt L
Larsson A
Ärnlöv J
Landman GWD
van Hateren KJJ
Kleefstra N
Chen J
Kwak L
Surapaneni A.
Chang, Ar
Grams, Me
Ballew, Sh
Bilo, H
Correa, A
Evans, M
Gutierrez, Om
Hosseinpanah F, Iseki K
Kenealy, T
Klein, B
Kronenberg, F
Lee, Bj
Li, Y
Miura, K
Navaneethan, Sd
Roderick, Pj
Valdivielso, Jm
Visseren, Flj
Zhang, L
Gansevoort, Rt
Hallan, Si
Levey, A
Matsushita, K
Shalev, V
Woodward, M
Astor, B
Appel, L
Greene, T
Chen, T
Chalmers, J
Arima, H
Perkovic, V
Yatsuya, H
Tamakoshi, K
Hirakawa, Y
Coresh, J
Sang, Y
Polkinghorne, K
Chadban, S
Atkins, R
Levin, A
Djurdjev, O
Klein, R
Lee, K
Liu, L
Zhao, M
Wang, F
Wang, J
Tang, M
Heine, G
Emrich, I
Zawada, A
Bauer, L
Nally, J
Schold, J
Shlipak, M
Sarnak, M
Katz, R
Hiramoto, J
Iso, H
Yamagishi, K
Umesawa, M
Muraki, I
Fukagawa, M
Maruyama, S
Hamano, T
Hasegawa, T
Fujii, N
Jafar, T
Hatcher, J
Poulter, N
Chaturvedi, N
Wheeler, D
Emberson, J
Townend, J
Landray, M
Brenner, H
Schöttker, B
Saum, Ku
Rothenbacher, D
Fox, C
Hwang, Sj
Köttgen, A
Schneider, Mp
Eckardt, Ku
Green, J
Kirchner, Hl
Ito, S
Miyazaki, M
Nakayama, M
Yamada, G
Cirillo, M
Romundstad, S
Øvrehus, M
Langlo, Ka
Irie, F
Sairenchi, T
Rebholz, Cm
Young, B
Boulware, Le
Ishikawa, S
Yano, Y
Kotani, K
Nakamura, T
Jee, Sh
Kimm, H
Mok, Y
Chodick, G
Wetzels, Jfm
Blankestijn, Pj
van Zuilen, Ad
Bots, M
Inker, L
Peralta, C
Kollerits, B
Ritz, E
Nitsch, D
Fletcher, A
Bottinger, E
Nadkarni, Gn
Ellis, Sb
Nadukuru, R
Fernandez, E
Betriu, A
Bermudez-Lopez, M
Stengel, B
Metzger, M
Flamant, M
Houillier, P
Haymann, Jp
Froissart, M
Ueshima, H
Okayama, A
Tanaka, S
Okamura, T
Elley, Cr
Collins, Jf
Drury, Pl
Ohkubo, T
Asayama, K
Metoki, H
Kikuya, M
Iseki, C
Nelson, Rg
Knowler, Wc
Bakker, Sjl
Heerspink, Hjl
Brunskill, N
Major, R
Shepherd, D
Medcalf, J
Jassal, Sk
Bergstrom, J
Ix, Jh
Barrett-Connor, E
Kovesdy, C
Kalantar-Zadeh, K
Sumida, K
Muntner, P
Warnock, D
Judd, S
Panwar, B
de Zeeuw, D
Brenner, B
Sedaghat, S
Ikram, Ma
Hoorn, Ej
Dehghan, A
Wong, Ty
Sabanayagam, C
Cheng, Cy
Banu, R
Segelmark, M
Stendahl, M
Schön, S
Tangri, N
Sud, M
Naimark, D
Wen, Cp
Tsao, Ck
Tsai, Mk
Chen, Ch
Konta, T
Hirayama, A
Ichikawa, K
Hadaegh, F
Mirbolouk, M
Azizi, F
Solbu, Md
Jenssen, Tg
Eriksen, Bo
Eggen, Ae
Lannfelt, L
Larsson, A
Ärnlöv, J
Landman, Gwd
van Hateren, Kjj
Kleefstra, N
Chen, J
Kwak, L
Surapaneni, A.
Lifestyle Medicine (LM)
Cardiovascular Centre (CVC)
Groningen Kidney Center (GKC)
Groningen Institute for Organ Transplantation (GIOT)
Real World Studies in PharmacoEpidemiology, -Genetics, -Economics and -Therapy (PEGET)
Asayama, Kei
Sedaghat, SeyyedMah
Source :
BMJ (Online), 364. BMJ Publishing Group, The BMJ, BMJ. British Medical Journal (Online), 364, k5301, BMJ. British Medical Journal (Online), 364, pp. k5301, BMJ-British Medical Journal, 364:5301. BMJ PUBLISHING GROUP, Repositorio Abierto de la UdL, Universitad de Lleida, 364:k5301, BMJ. British Medical Journal, Recercat. Dipósit de la Recerca de Catalunya, instname
Publication Year :
2019

Abstract

ObjectiveTo evaluate the associations between adiposity measures (body mass index, waist circumference, and waist-to-height ratio) with decline in glomerular filtration rate (GFR) and with all cause mortality.DesignIndividual participant data meta-analysis.SettingCohorts from 40 countries with data collected between 1970 and 2017.ParticipantsAdults in 39 general population cohorts (n=5 459 014), of which 21 (n=594 496) had data on waist circumference; six cohorts with high cardiovascular risk (n=84 417); and 18 cohorts with chronic kidney disease (n=91 607).Main outcome measuresGFR decline (estimated GFR decline ≥40%, initiation of kidney replacement therapy or estimated GFR 2) and all cause mortality.ResultsOver a mean follow-up of eight years, 246 607 (5.6%) individuals in the general population cohorts had GFR decline (18 118 (0.4%) end stage kidney disease events) and 782 329 (14.7%) died. Adjusting for age, sex, race, and current smoking, the hazard ratios for GFR decline comparing body mass indices 30, 35, and 40 with body mass index 25 were 1.18 (95% confidence interval 1.09 to 1.27), 1.69 (1.51 to 1.89), and 2.02 (1.80 to 2.27), respectively. Results were similar in all subgroups of estimated GFR. Associations weakened after adjustment for additional comorbidities, with respective hazard ratios of 1.03 (0.95 to 1.11), 1.28 (1.14 to 1.44), and 1.46 (1.28 to 1.67). The association between body mass index and death was J shaped, with the lowest risk at body mass index of 25. In the cohorts with high cardiovascular risk and chronic kidney disease (mean follow-up of six and four years, respectively), risk associations between higher body mass index and GFR decline were weaker than in the general population, and the association between body mass index and death was also J shaped, with the lowest risk between body mass index 25 and 30. In all cohort types, associations between higher waist circumference and higher waist-to-height ratio with GFR decline were similar to that of body mass index; however, increased risk of death was not associated with lower waist circumference or waist-to-height ratio, as was seen with body mass index.ConclusionsElevated body mass index, waist circumference, and waist-to-height ratio are independent risk factors for GFR decline and death in individuals who have normal or reduced levels of estimated GFR.

Details

Language :
English
ISSN :
09598146 and 17561833
Database :
OpenAIRE
Journal :
BMJ (Online), 364. BMJ Publishing Group, The BMJ, BMJ. British Medical Journal (Online), 364, k5301, BMJ. British Medical Journal (Online), 364, pp. k5301, BMJ-British Medical Journal, 364:5301. BMJ PUBLISHING GROUP, Repositorio Abierto de la UdL, Universitad de Lleida, 364:k5301, BMJ. British Medical Journal, Recercat. Dipósit de la Recerca de Catalunya, instname
Accession number :
edsair.doi.dedup.....0683bf7b2558b2c33d54b567faf15518